Clinics I work with
Selected research
-
Genetic and immunologic features of recurrent stage I lung adenocarcinoma.
Scientific reports
-
Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay.
Future oncology (London, England)
-
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy.
Clinical lung cancer
Contact me
- Request appointment
- Refer a patient
- (415) 885-3882